Results 21 to 30 of about 88,938 (144)

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide [PDF]

Patient Preference and Adherence, 2019
Erminia Ridolo,1 Irene Pellicelli,1 Bruna Gritti,2 Cristoforo Incorvaia2 1Allergy and Clinical Immunology, Medicine and Surgery Department, University of Parma, Parma, Italy; 2Cardiac/Pulmonary Rehabilitation Unit, ASST Pini-CTO, Milan, Italy Abstract:
Ridolo E, Pellicelli I, Gritti B, Incorvaia C   +3 more
doaj   +2 more sources

Glycopyrronium bromide is a new long-acting anticholinergic drug for the treatment of COPD

Медицинский совет, 2014
Glycopyrronium is a new powerful quick-acting anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease. Glycopyrronium is powder in Breezhaler® inhalation device.
S. N. Avdeev, S. Y. Chikina
doaj   +2 more sources

BRONCHOPROTECTIVE EFFECT OF GLYCOPYRRONIUM BROMIDE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE [PDF]

Медицинский совет, 2017
Bronchial hyperreactivity (BHR) is one of the functional characteristics of chronic obstructive pulmonary disease (COPD) and is present in most patients with this disease.
I. N. Trofimenko, M. V. Genova, B. A. Chernyak   +2 more
doaj   +2 more sources

Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis

International Journal of COPD, 2013
Andreas Karabis,1 Leandro Lindner,2 Michelle Mocarski,3 Eline Huisman,1 Andrew Greening4 1MAPI Consultancy, AX Houten, The Netherlands; 2Almirall SA, Barcelona, Spain; 3Health Economics and Outcomes Research, Forest Research Institute, Jersey City, NJ ...
Karabis A, Lindner L, Mocarski M, Huisman E, Greening A   +4 more
doaj   +1 more source

Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo. [PDF]

Br J Pharmacol, 2020
Combining inhaled corticosteroids (ICSs), long-acting β2 -adrenoceptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) is recommended to treat severe forms of asthma and chronic obstructive pulmonary disease (COPD). Clinical benefits have
Rogliani P, Matera MG, Facciolo F, Page C, Cazzola M, Calzetta L.   +5 more
europepmc   +3 more sources

Clinical Characteristics and Treatment Patterns of Hyperhidrosis in Northern Hokkaido: A Single-Center Retrospective Descriptive Study. [PDF]

J Dermatol
ABSTRACT Hyperhidrosis is a common condition associated with a substantial negative impact on the quality of life. Several studies have described the clinical characteristics and disease burden of patients with hyperhidrosis in Japan. However, comparable real‐world clinical data on hyperhidrosis from Hokkaido remain limited. We therefore evaluated real‐
Kishibe M, Noguchi A, Matsuya M, Matsumoto K, Igawa S, Fujita Y.   +5 more
europepmc   +2 more sources

Feasibility of testing bronchodilator responsiveness with glycopyrronium in obstructive airway diseases: the initial appraisal of the pilot experience

The Journal of Association of Chest Physicians, 2021
Background: The short onset of action of glycopyrronium bromide, makes it a suitable antimuscarinic agent to test bronchodilator-responsiveness in airway diseases. The objective of the study was to explore the feasibility of the testing so.
Parthasarathi Bhattacharyya, Dipanjan Saha, Sayoni Sengupta, Debkanya De   +3 more
doaj   +1 more source

POTENTIOMETRIC DETERMINATION OF GLYCOPYRRONIUM BROMIDE IN BINARY MIXTURE WITH INDACATEROL MALEATE USING POLYVINYL CHLORIDE (PVC) MEMBRANE, COATED GRAPHITE AND CARBON PASTE SENSORS [PDF]

Al-Azhar Journal of Pharmaceutical Sciences, 2018
A novel approach was conducted in this article for the determination of glycopyrronium bromide (GLY) in binary mixture with indacaterol maleate using ion selective electrodes for its selective determination in pure form and pharmaceutical formulation ...
Mohammed El Dosoky
doaj   +1 more source

COPD and glycopyrronium responsiveness assessment: An appraisal

Lung India, 2023
Clinical Trial Registration: ECR/159/Inst/WB/2013/RR-20 Background: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agonist ...
Parthasarathi Bhattacharyya, Dipanjan Saha, Moumita Chatterjee, Sayoni Sengupta, Debkanya Dey, Rajat Banerjee   +5 more
doaj   +1 more source

The double bronchodilation era: new capabilities in a new drug delivery device

Медицинский совет, 2022
A literature review presents the efficacy and safety of the new glycopyrronium bromide/formoterol fumarate (GP/FF) combination in the treatment of patients with chronic obstructive pulmonary disease according to the PINNACLE 1, 2, 3, 4 studies. There are
E. A. Orlova, I. P. Dorfman, M. A. Orlov, M. A. Abdullaev   +3 more
doaj   +1 more source